trending Market Intelligence /marketintelligence/en/news-insights/trending/_W4dU0_YxQJOXBbguGyx2g2 content esgSubNav
In This List

Diagnostics company Natera names CEO, COO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Diagnostics company Natera names CEO, COO

Natera Inc. appointed Steve Chapman as CEO and Robert Schueren as COO, effective Jan. 2 and Jan. 7, respectively.

Chapman, who was previously the company's COO, will succeed Matthew Rabinowitz, who is the co-founder and CEO of Natera.

Meanwhile, Rabinowitz will remain involved as executive chairman.

Schueren has served in executive leadership roles at companies including Genentech Inc., Agilent Technologies Inc. and IntegenX Inc., which was recently acquired by Thermo Fisher Scientific Inc.

San Carlos, Calif.-based Natera is a diagnostics company, which provides preconception and prenatal genetic testing services. It mainly offers a non-invasive prenatal test called Panorama, which screens for chromosomal abnormalities of a fetus with blood drawn from the mother.